• FAQ
Prophase Logo
open menu
  • About Us
    • About Us
    • Management Team
  • Our Companies
    • Nebula Genomics
    • ProPhase Diagnostics
    • ProPhase Biopharma
    • Pharmaloz Manufacturing
    • TK Supplements
  • Investor Relations
    • Presentations
    • News & Events
      • Press Releases
      • Media Mentions
      • IR Calendar
      • Email Alerts
    • Company Info
      • Management Team
      • Contacts
      • FAQ
    • Financial Info
      • Financial Results
      • Income Statement
      • Balance Sheet
      • Cash Flow
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
  • Contact Us
    • Corporate
    • Diagnostics
    • Pharmaloz
    • TKSupplements

Press Releases

Investors

Investors

  • Overview
  • Presentations
  • News & Events
    • Press Releases
    • Media Mentions
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • Media Mentions
  • IR Calendar
  • Email Alerts
Mar 30, 2021 5:10pm EDT

ProPhase Labs Acquires Digital Covid Vaccination and Testing “Passport” Solution

Mar 15, 2021 8:30am EDT

ProPhase Labs to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Wednesday, March 31, 2021 at 4:30 p.m. Eastern Time

Feb 09, 2021 8:30am EST

ProPhase Labs Begins Advanced, Saliva-based Viral PCR Multiplex-Testing for COVID-19, Influenza A & B, and Other Viruses After FDA Confirmation of Two Emergency Use Authorizations

Feb 01, 2021 8:30am EST

ProPhase Labs Exceeding Initial Goals as Covid-19 Lab Testing Business Ramps up

Jan 29, 2021 8:30am EST

ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York

Jan 21, 2021 4:30pm EST

ProPhase Labs, Inc. Announces Closing of Public Offering

Jan 18, 2021 9:50pm EST

ProPhase Labs Announces Pricing of Public Offering of Common Stock

Jan 15, 2021 5:21pm EST

ProPhase Labs Announces Proposed Public Offering of Common Stock

Jan 11, 2021 8:30am EST

ProPhase Labs to Present at the NobleCon17 Annual Small & Microcap Investor Conference on Tuesday, January 19, 2021 at 12:45 p.m. Eastern Time

Jan 05, 2021 12:10pm EST

ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants

  • arrow_back
  • 1…
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • …24
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Prophase Logo

© Copyright - ProPhase Labs, Inc.
All Rights Reserved.

  • About Us
  • Our Companies
  • Investor Relations
  • Contact Us
  • Site Map
  • Legal Notice
  • Accessibility